APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Medicine Diagnostic Equipment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nuclear Medicine Diagnostic Equipment Market Outlook and Growth Opportunities 2026

26 December 2025208 pages

Choose your research edition.

Industry ResearchNuclear Medicine Diagnostic Equipment Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Medicine Diagnostic Equipment Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Nuclear Medicine Diagnostic Equipment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Medicine Diagnostic Equipment Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Medicine Diagnostic Equipment Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Nuclear Medicine Diagnostic Equipment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nuclear Medicine Diagnostic Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nuclear Medicine Diagnostic Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nuclear Medicine Diagnostic Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nuclear Medicine Diagnostic Equipment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nuclear Medicine Diagnostic Equipment market include GE HealthCare, Siemens Healthineers, CMR Naviscan, Compañía Mexicana, DDD-Diagnostic, Digirad, Mediso Medical Imaging Systems, Philips and Positron, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nuclear Medicine Diagnostic Equipment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nuclear Medicine Diagnostic Equipment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nuclear Medicine Diagnostic Equipment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nuclear Medicine Diagnostic Equipment market size, projected growth trends, production technologies, key applications, and end-use industries.

Nuclear Medicine Diagnostic Equipment Segment by Company

GE HealthCare

Siemens Healthineers

CMR Naviscan

Compañía Mexicana

DDD-Diagnostic

Digirad

Mediso Medical Imaging Systems

Philips

Positron

SurgicEye

TeraRecon

Toshiba

Top Grade Healthcare

Neusoft Group

United Imaging

MinFound Medical

SinoUnion Healthcare

Nuclear Medicine Diagnostic Equipment Segment by Type

PET

SPECT

Nuclear Medicine Diagnostic Equipment Segment by Application

Tumor Imaging

Endocrine System Imaging

Urinary System Imaging

Bone Marrow Imaging

Others

Nuclear Medicine Diagnostic Equipment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nuclear Medicine Diagnostic Equipment status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nuclear Medicine Diagnostic Equipment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nuclear Medicine Diagnostic Equipment significant trends, drivers, influence factors in global and regions.

6. To analyze Nuclear Medicine Diagnostic Equipment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Diagnostic Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Diagnostic Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Diagnostic Equipment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nuclear Medicine Diagnostic Equipment market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nuclear Medicine Diagnostic Equipment industry.

Chapter 3: Detailed analysis of Nuclear Medicine Diagnostic Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nuclear Medicine Diagnostic Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nuclear Medicine Diagnostic Equipment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nuclear Medicine Diagnostic Equipment Industry Trends Table 2. Nuclear Medicine Diagnostic Equipment Industry Drivers Table 3. Nuclear Medicine Diagnostic Equipment Industry Opportunities and Challenges Table 4. Nuclear Medicine Diagnostic Equipment Industry Restraints Table 5. Global Nuclear Medicine Diagnostic Equipment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nuclear Medicine Diagnostic Equipment Revenue Share by Company (2021-2026) Table 7. Global Nuclear Medicine Diagnostic Equipment Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Nuclear Medicine Diagnostic Equipment Sales Volume Share by Company (2021-2026) Table 9. Global Nuclear Medicine Diagnostic Equipment Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Nuclear Medicine Diagnostic Equipment Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nuclear Medicine Diagnostic Equipment Key Company Manufacturing Base & Headquarters Table 12. Global Nuclear Medicine Diagnostic Equipment Company, Product Type & Application Table 13. Global Nuclear Medicine Diagnostic Equipment Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nuclear Medicine Diagnostic Equipment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of PET Table 18. Significant Companies of SPECT Table 19. Global Nuclear Medicine Diagnostic Equipment Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Nuclear Medicine Diagnostic Equipment Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Nuclear Medicine Diagnostic Equipment Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Nuclear Medicine Diagnostic Equipment Sales Volume Share by Type (2021-2026) Table 23. Global Nuclear Medicine Diagnostic Equipment Sales Volume Share by Type (2027-2032) Table 24. Global Nuclear Medicine Diagnostic Equipment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Nuclear Medicine Diagnostic Equipment Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Nuclear Medicine Diagnostic Equipment Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Nuclear Medicine Diagnostic Equipment Sales Value Share by Type (2021-2026) Table 28. Global Nuclear Medicine Diagnostic Equipment Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Tumor Imaging Table 30. Significant Companies of Endocrine System Imaging Table 31. Significant Companies of Urinary System Imaging Table 32. Significant Companies of Bone Marrow Imaging Table 33. Significant Companies of Others Table 34. Global Nuclear Medicine Diagnostic Equipment Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Nuclear Medicine Diagnostic Equipment Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Nuclear Medicine Diagnostic Equipment Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Nuclear Medicine Diagnostic Equipment Sales Volume Share by Application (2021-2026) Table 38. Global Nuclear Medicine Diagnostic Equipment Sales Volume Share by Application (2027-2032) Table 39. Global Nuclear Medicine Diagnostic Equipment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Nuclear Medicine Diagnostic Equipment Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Nuclear Medicine Diagnostic Equipment Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Nuclear Medicine Diagnostic Equipment Sales Value Share by Application (2021-2026) Table 43. Global Nuclear Medicine Diagnostic Equipment Sales Value Share by Application (2027-2032) Table 44. Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Nuclear Medicine Diagnostic Equipment Sales by Region (2021-2026) & (K Units) Table 46. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Region (2021-2026) Table 47. Global Nuclear Medicine Diagnostic Equipment Sales by Region (2027-2032) & (K Units) Table 48. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Region (2027-2032) Table 49. Global Nuclear Medicine Diagnostic Equipment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Nuclear Medicine Diagnostic Equipment Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Nuclear Medicine Diagnostic Equipment Sales Value Share by Region (2021-2026) Table 52. Global Nuclear Medicine Diagnostic Equipment Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Nuclear Medicine Diagnostic Equipment Sales Value Share by Region (2027-2032) Table 54. Global Nuclear Medicine Diagnostic Equipment Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Nuclear Medicine Diagnostic Equipment Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Nuclear Medicine Diagnostic Equipment Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Nuclear Medicine Diagnostic Equipment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026) & (K Units) Table 59. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2021-2026) Table 60. Global Nuclear Medicine Diagnostic Equipment Sales by Country (2027-2032) & (K Units) Table 61. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Country (2027-2032) Table 62. Global Nuclear Medicine Diagnostic Equipment Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Nuclear Medicine Diagnostic Equipment Sales Value Market Share by Country (2021-2026) Table 64. Global Nuclear Medicine Diagnostic Equipment Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Nuclear Medicine Diagnostic Equipment Sales Value Market Share by Country (2027-2032) Table 66. GE HealthCare Company Information Table 67. GE HealthCare Business Overview Table 68. GE HealthCare Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolio Table 70. GE HealthCare Recent Development Table 71. Siemens Healthineers Company Information Table 72. Siemens Healthineers Business Overview Table 73. Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolio Table 75. Siemens Healthineers Recent Development Table 76. CMR Naviscan Company Information Table 77. CMR Naviscan Business Overview Table 78. CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolio Table 80. CMR Naviscan Recent Development Table 81. Compañía Mexicana Company Information Table 82. Compañía Mexicana Business Overview Table 83. Compañía Mexicana Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Compañía Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolio Table 85. Compañía Mexicana Recent Development Table 86. DDD-Diagnostic Company Information Table 87. DDD-Diagnostic Business Overview Table 88. DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolio Table 90. DDD-Diagnostic Recent Development Table 91. Digirad Company Information Table 92. Digirad Business Overview Table 93. Digirad Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Digirad Nuclear Medicine Diagnostic Equipment Product Portfolio Table 95. Digirad Recent Development Table 96. Mediso Medical Imaging Systems Company Information Table 97. Mediso Medical Imaging Systems Business Overview Table 98. Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolio Table 100. Mediso Medical Imaging Systems Recent Development Table 101. Philips Company Information Table 102. Philips Business Overview Table 103. Philips Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Philips Nuclear Medicine Diagnostic Equipment Product Portfolio Table 105. Philips Recent Development Table 106. Positron Company Information Table 107. Positron Business Overview Table 108. Positron Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Positron Nuclear Medicine Diagnostic Equipment Product Portfolio Table 110. Positron Recent Development Table 111. SurgicEye Company Information Table 112. SurgicEye Business Overview Table 113. SurgicEye Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolio Table 115. SurgicEye Recent Development Table 116. TeraRecon Company Information Table 117. TeraRecon Business Overview Table 118. TeraRecon Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolio Table 120. TeraRecon Recent Development Table 121. Toshiba Company Information Table 122. Toshiba Business Overview Table 123. Toshiba Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolio Table 125. Toshiba Recent Development Table 126. Top Grade Healthcare Company Information Table 127. Top Grade Healthcare Business Overview Table 128. Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio Table 130. Top Grade Healthcare Recent Development Table 131. Neusoft Group Company Information Table 132. Neusoft Group Business Overview Table 133. Neusoft Group Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolio Table 135. Neusoft Group Recent Development Table 136. United Imaging Company Information Table 137. United Imaging Business Overview Table 138. United Imaging Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolio Table 140. United Imaging Recent Development Table 141. MinFound Medical Company Information Table 142. MinFound Medical Business Overview Table 143. MinFound Medical Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolio Table 145. MinFound Medical Recent Development Table 146. SinoUnion Healthcare Company Information Table 147. SinoUnion Healthcare Business Overview Table 148. SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio Table 150. SinoUnion Healthcare Recent Development Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Nuclear Medicine Diagnostic Equipment Distributors List Table 154. Nuclear Medicine Diagnostic Equipment Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Nuclear Medicine Diagnostic Equipment Product Image Figure 2. Global Nuclear Medicine Diagnostic Equipment Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nuclear Medicine Diagnostic Equipment Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nuclear Medicine Diagnostic Equipment Sales (2021-2032) & (K Units) Figure 5. Global Nuclear Medicine Diagnostic Equipment Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Nuclear Medicine Diagnostic Equipment Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. PET Image Figure 10. SPECT Image Figure 11. Global Nuclear Medicine Diagnostic Equipment Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Nuclear Medicine Diagnostic Equipment Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Nuclear Medicine Diagnostic Equipment Sales Volume Share by Type (2021-2032) Figure 14. Global Nuclear Medicine Diagnostic Equipment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Nuclear Medicine Diagnostic Equipment Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Nuclear Medicine Diagnostic Equipment Sales Value Share by Type (2021-2032) Figure 17. Tumor Imaging Image Figure 18. Endocrine System Imaging Image Figure 19. Urinary System Imaging Image Figure 20. Bone Marrow Imaging Image Figure 21. Others Image Figure 22. Global Nuclear Medicine Diagnostic Equipment Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Nuclear Medicine Diagnostic Equipment Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Nuclear Medicine Diagnostic Equipment Sales Volume Share by Application (2021-2032) Figure 25. Global Nuclear Medicine Diagnostic Equipment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Nuclear Medicine Diagnostic Equipment Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Nuclear Medicine Diagnostic Equipment Sales Value Share by Application (2021-2032) Figure 28. Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Nuclear Medicine Diagnostic Equipment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Nuclear Medicine Diagnostic Equipment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Nuclear Medicine Diagnostic Equipment Sales Value (2021-2032) & (US$ Million) Figure 33. North America Nuclear Medicine Diagnostic Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Nuclear Medicine Diagnostic Equipment Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Nuclear Medicine Diagnostic Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Nuclear Medicine Diagnostic Equipment Sales Value (2021-2032) & (US$ Million) Figure 39. South America Nuclear Medicine Diagnostic Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Nuclear Medicine Diagnostic Equipment Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Nuclear Medicine Diagnostic Equipment Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • PET
  • SPECT
Applications
  • Tumor Imaging
  • Endocrine System Imaging
  • Urinary System Imaging
  • Bone Marrow Imaging
  • Others
Companies covered
  • GE HealthCare
  • Siemens Healthineers
  • CMR Naviscan
  • Compañía Mexicana
  • DDD-Diagnostic
  • Digirad
  • Mediso Medical Imaging Systems
  • Philips
  • Positron
  • SurgicEye
  • TeraRecon
  • Toshiba
  • Top Grade Healthcare
  • Neusoft Group
  • United Imaging
  • MinFound Medical
  • SinoUnion Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nuclear Medicine Diagnostic Equipment Sales Value (2021-2032)
  4. 1.2.2 Global Nuclear Medicine Diagnostic Equipment Sales Volume (2021-2032)
  5. 1.2.3 Global Nuclear Medicine Diagnostic Equipment Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nuclear Medicine Diagnostic Equipment Market Dynamics
  1. 2.1 Nuclear Medicine Diagnostic Equipment Industry Trends
  2. 2.2 Nuclear Medicine Diagnostic Equipment Industry Drivers
  3. 2.3 Nuclear Medicine Diagnostic Equipment Industry Opportunities and Challenges
  4. 2.4 Nuclear Medicine Diagnostic Equipment Industry Restraints
3 Nuclear Medicine Diagnostic Equipment Market by Company
  1. 3.1 Global Nuclear Medicine Diagnostic Equipment Company Revenue Ranking in 2025
  2. 3.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Company (2021-2026)
  3. 3.3 Global Nuclear Medicine Diagnostic Equipment Sales Volume by Company (2021-2026)
  4. 3.4 Global Nuclear Medicine Diagnostic Equipment Average Price by Company (2021-2026)
  5. 3.5 Global Nuclear Medicine Diagnostic Equipment Company Ranking (2024-2026)
  6. 3.6 Global Nuclear Medicine Diagnostic Equipment Company Manufacturing Base and Headquarters
  7. 3.7 Global Nuclear Medicine Diagnostic Equipment Company Product Type and Application
  8. 3.8 Global Nuclear Medicine Diagnostic Equipment Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nuclear Medicine Diagnostic Equipment Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nuclear Medicine Diagnostic Equipment Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nuclear Medicine Diagnostic Equipment Market by Type
  1. 4.1 Nuclear Medicine Diagnostic Equipment Type Introduction
  2. 4.1.1 PET
  3. 4.1.2 SPECT
  4. 4.2 Global Nuclear Medicine Diagnostic Equipment Sales Volume by Type
  5. 4.2.1 Global Nuclear Medicine Diagnostic Equipment Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nuclear Medicine Diagnostic Equipment Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Nuclear Medicine Diagnostic Equipment Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Nuclear Medicine Diagnostic Equipment Sales Value by Type
  9. 4.3.1 Global Nuclear Medicine Diagnostic Equipment Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nuclear Medicine Diagnostic Equipment Sales Value by Type (2021-2032)
  11. 4.3.3 Global Nuclear Medicine Diagnostic Equipment Sales Value Share by Type (2021-2032)
5 Nuclear Medicine Diagnostic Equipment Market by Application
  1. 5.1 Nuclear Medicine Diagnostic Equipment Application Introduction
  2. 5.1.1 Tumor Imaging
  3. 5.1.2 Endocrine System Imaging
  4. 5.1.3 Urinary System Imaging
  5. 5.1.4 Bone Marrow Imaging
  6. 5.1.5 Others
  7. 5.2 Global Nuclear Medicine Diagnostic Equipment Sales Volume by Application
  8. 5.2.1 Global Nuclear Medicine Diagnostic Equipment Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Nuclear Medicine Diagnostic Equipment Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Nuclear Medicine Diagnostic Equipment Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Nuclear Medicine Diagnostic Equipment Sales Value by Application
  12. 5.3.1 Global Nuclear Medicine Diagnostic Equipment Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Nuclear Medicine Diagnostic Equipment Sales Value by Application (2021-2032)
  14. 5.3.3 Global Nuclear Medicine Diagnostic Equipment Sales Value Share by Application (2021-2032)
6 Nuclear Medicine Diagnostic Equipment Regional Sales and Value Analysis
  1. 6.1 Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nuclear Medicine Diagnostic Equipment Sales by Region (2021-2032)
  3. 6.2.1 Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2021-2026
  4. 6.2.2 Global Nuclear Medicine Diagnostic Equipment Sales by Region (2027-2032)
  5. 6.3 Global Nuclear Medicine Diagnostic Equipment Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nuclear Medicine Diagnostic Equipment Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nuclear Medicine Diagnostic Equipment Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nuclear Medicine Diagnostic Equipment Sales Value by Region (2027-2032)
  9. 6.5 Global Nuclear Medicine Diagnostic Equipment Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nuclear Medicine Diagnostic Equipment Sales Value (2021-2032)
  12. 6.6.2 North America Nuclear Medicine Diagnostic Equipment Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nuclear Medicine Diagnostic Equipment Sales Value (2021-2032)
  15. 6.7.2 Europe Nuclear Medicine Diagnostic Equipment Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nuclear Medicine Diagnostic Equipment Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nuclear Medicine Diagnostic Equipment Sales Value (2021-2032)
  21. 6.9.2 South America Nuclear Medicine Diagnostic Equipment Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nuclear Medicine Diagnostic Equipment Sales Value Share by Country, 2025 VS 2032
7 Nuclear Medicine Diagnostic Equipment Country-level Sales and Value Analysis
  1. 7.1 Global Nuclear Medicine Diagnostic Equipment Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nuclear Medicine Diagnostic Equipment Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2032)
  4. 7.3.1 Global Nuclear Medicine Diagnostic Equipment Sales by Country (2021-2026)
  5. 7.3.2 Global Nuclear Medicine Diagnostic Equipment Sales by Country (2027-2032)
  6. 7.4 Global Nuclear Medicine Diagnostic Equipment Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nuclear Medicine Diagnostic Equipment Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nuclear Medicine Diagnostic Equipment Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nuclear Medicine Diagnostic Equipment Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nuclear Medicine Diagnostic Equipment Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nuclear Medicine Diagnostic Equipment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GE HealthCare
  2. 8.1.1 GE HealthCare Company Information
  3. 8.1.2 GE HealthCare Business Overview
  4. 8.1.3 GE HealthCare Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolio
  6. 8.1.5 GE HealthCare Recent Developments
  7. 8.2 Siemens Healthineers
  8. 8.2.1 Siemens Healthineers Company Information
  9. 8.2.2 Siemens Healthineers Business Overview
  10. 8.2.3 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolio
  12. 8.2.5 Siemens Healthineers Recent Developments
  13. 8.3 CMR Naviscan
  14. 8.3.1 CMR Naviscan Company Information
  15. 8.3.2 CMR Naviscan Business Overview
  16. 8.3.3 CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolio
  18. 8.3.5 CMR Naviscan Recent Developments
  19. 8.4 Compañía Mexicana
  20. 8.4.1 Compañía Mexicana Company Information
  21. 8.4.2 Compañía Mexicana Business Overview
  22. 8.4.3 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolio
  24. 8.4.5 Compañía Mexicana Recent Developments
  25. 8.5 DDD-Diagnostic
  26. 8.5.1 DDD-Diagnostic Company Information
  27. 8.5.2 DDD-Diagnostic Business Overview
  28. 8.5.3 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolio
  30. 8.5.5 DDD-Diagnostic Recent Developments
  31. 8.6 Digirad
  32. 8.6.1 Digirad Company Information
  33. 8.6.2 Digirad Business Overview
  34. 8.6.3 Digirad Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Digirad Nuclear Medicine Diagnostic Equipment Product Portfolio
  36. 8.6.5 Digirad Recent Developments
  37. 8.7 Mediso Medical Imaging Systems
  38. 8.7.1 Mediso Medical Imaging Systems Company Information
  39. 8.7.2 Mediso Medical Imaging Systems Business Overview
  40. 8.7.3 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolio
  42. 8.7.5 Mediso Medical Imaging Systems Recent Developments
  43. 8.8 Philips
  44. 8.8.1 Philips Company Information
  45. 8.8.2 Philips Business Overview
  46. 8.8.3 Philips Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Philips Nuclear Medicine Diagnostic Equipment Product Portfolio
  48. 8.8.5 Philips Recent Developments
  49. 8.9 Positron
  50. 8.9.1 Positron Company Information
  51. 8.9.2 Positron Business Overview
  52. 8.9.3 Positron Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Positron Nuclear Medicine Diagnostic Equipment Product Portfolio
  54. 8.9.5 Positron Recent Developments
  55. 8.10 SurgicEye
  56. 8.10.1 SurgicEye Company Information
  57. 8.10.2 SurgicEye Business Overview
  58. 8.10.3 SurgicEye Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolio
  60. 8.10.5 SurgicEye Recent Developments
  61. 8.11 TeraRecon
  62. 8.11.1 TeraRecon Company Information
  63. 8.11.2 TeraRecon Business Overview
  64. 8.11.3 TeraRecon Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolio
  66. 8.11.5 TeraRecon Recent Developments
  67. 8.12 Toshiba
  68. 8.12.1 Toshiba Company Information
  69. 8.12.2 Toshiba Business Overview
  70. 8.12.3 Toshiba Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolio
  72. 8.12.5 Toshiba Recent Developments
  73. 8.13 Top Grade Healthcare
  74. 8.13.1 Top Grade Healthcare Company Information
  75. 8.13.2 Top Grade Healthcare Business Overview
  76. 8.13.3 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
  78. 8.13.5 Top Grade Healthcare Recent Developments
  79. 8.14 Neusoft Group
  80. 8.14.1 Neusoft Group Company Information
  81. 8.14.2 Neusoft Group Business Overview
  82. 8.14.3 Neusoft Group Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolio
  84. 8.14.5 Neusoft Group Recent Developments
  85. 8.15 United Imaging
  86. 8.15.1 United Imaging Company Information
  87. 8.15.2 United Imaging Business Overview
  88. 8.15.3 United Imaging Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolio
  90. 8.15.5 United Imaging Recent Developments
  91. 8.16 MinFound Medical
  92. 8.16.1 MinFound Medical Company Information
  93. 8.16.2 MinFound Medical Business Overview
  94. 8.16.3 MinFound Medical Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolio
  96. 8.16.5 MinFound Medical Recent Developments
  97. 8.17 SinoUnion Healthcare
  98. 8.17.1 SinoUnion Healthcare Company Information
  99. 8.17.2 SinoUnion Healthcare Business Overview
  100. 8.17.3 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
  102. 8.17.5 SinoUnion Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nuclear Medicine Diagnostic Equipment Value Chain Analysis
  2. 9.1.1 Nuclear Medicine Diagnostic Equipment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nuclear Medicine Diagnostic Equipment Sales Mode & Process
  6. 9.2 Nuclear Medicine Diagnostic Equipment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nuclear Medicine Diagnostic Equipment Distributors
  9. 9.2.3 Nuclear Medicine Diagnostic Equipment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst